tirzepatide and alzheimer's Tirzepatide: a novel therapeutic approach for disease | Metabolic Brain Disease A novel therapeutic prospect: a

We present a case of a 48-year-old woman with type 2 diabetes, who developed persistent nausea and vomiting after resuming semaglutide at 2 mg subcutaneously once weekly without following the recommended stepwise titration schedule (typically initiated at 0.25 mg weekly with gradual escalation)

This diet guide breaks down what to eat, what to avoid & how low-sugar drinks like Mingle Mocktails fit your routine.

Dean Jones, DC, a holistic obesity expert dedicated to helping people achieve sustainable weight loss and graduate to medication independence

Are we, as a drinks industry, deeply underestimating the impact of GLP-1s

Designed to complement GLP-1 routines and active lifestyles

It works by mimicking the effects of two hormones, GLP-1 and GIP, which help regulate blood sugar levels and appetite